EUVIMEDEUVIMED entdecken
Open Access

R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure

Emre Hafızoğlu iD, Mehmet Salim Demir iD

Medical Science Monitor · 2025

DOI: 10.12659/msm.951530 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Science Monitor, 2025. Verfasst von Emre Hafızoğlu und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey. Hauptthemen laut MEDLINE: Stomach Neoplasms. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsHumansFemaleMaleMiddle AgedAgedRetrospective StudiesGastrectomyPrognosisNeoplasm Recurrence, LocalAdultBiomarkers, TumorAdenocarcinomaMargins of ExcisionNeoplasm Staging

Substanzen

Biomarkers, Tumor

Autor:innen und Institutionen

  • Department of Medical Oncology, Afyonkarahisar State Hospital, Afyonkarahisar, Turkey.
  • Department of Medical Oncology, Van Training and Research Hospital, Van, Turkey.

ORCID-Profile: Emre Hafızoğlu, Mehmet Salim Demir

Zitieren

APA

Hafızoğlu, E., & Demir, M. S. (2025). R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure. Medical Science Monitor. https://doi.org/10.12659/msm.951530

Vancouver

Hafızoğlu E, Demir MS. R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure. Medical Science Monitor. 2025. doi:10.12659/msm.951530

BibTeX
@article{Hafzolu2025,
  author = {Hafızoğlu, Emre and Demir, Mehmet Salim},
  title = {R1 Resection in Gastric Cancer: Marker of Tumor Biology Rather Than Surgical Failure},
  journal = {Medical Science Monitor},
  year = {2025},
  doi = {10.12659/msm.951530}
}
Kostenlos starten →